These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 31365803)

  • 1. Cutaneous Ulcerations in Anti-MDA5 Dermatomyositis.
    Charrow A; Vleugels RA
    N Engl J Med; 2019 Aug; 381(5):465. PubMed ID: 31365803
    [No Abstract]   [Full Text] [Related]  

  • 2. Anti-MDA-5-positive amyopathic dermatomyositis with cutaneous ulcerations.
    Chen Y; Teng GG; Teo WZ
    Med J Aust; 2021 Jul; 215(1):21-21.e1. PubMed ID: 34028032
    [No Abstract]   [Full Text] [Related]  

  • 3. Bosentan for Cutaneous Ulcers in Anti-MDA5 Dermatomyositis.
    Combalia A; Giavedoni P; Tamez L; Grau-Junyent JM; Mascaró JM
    JAMA Dermatol; 2018 Mar; 154(3):371-373. PubMed ID: 29344607
    [No Abstract]   [Full Text] [Related]  

  • 4. Panniculitis as the initial manifestation of dermatomyositis with anti-MDA5 antibody.
    Hasegawa A; Shimomura Y; Kibune N; Koshio J; Umemori Y; Abe R
    Clin Exp Dermatol; 2017 Jul; 42(5):551-553. PubMed ID: 28543278
    [No Abstract]   [Full Text] [Related]  

  • 5. Digital Pulp Ulcerations and Inverse Gottron Papules in Melanoma Differentiation-Associated Gene 5-Related Dermatomyositis.
    Ward I; Hiles P; Arroyo R; Downs W; Bell D
    J Clin Rheumatol; 2016 Aug; 22(5):274-5. PubMed ID: 27464773
    [No Abstract]   [Full Text] [Related]  

  • 6. Anti-MDA5-Positive Dermatomyositis: A Description of the Cutaneous and Systemic Manifestations in 2 Cases.
    Barrientos N; Sicilia JJ; Moreno de Vega MJ; Dominguez JD
    Actas Dermosifiliogr (Engl Ed); 2018 Mar; 109(2):188-190. PubMed ID: 29162227
    [No Abstract]   [Full Text] [Related]  

  • 7. Pharyngeal ulceration and perforation: a rare manifestation in anti-MDA5 dermatomyositis.
    Luo L; Huang W; Ren F; Zhou J; Huang D; Tang L
    Rheumatology (Oxford); 2021 Apr; 60(4):e132-e133. PubMed ID: 33197245
    [No Abstract]   [Full Text] [Related]  

  • 8. Image Gallery: Cutaneous ulcers in anti-MDA5 dermatomyositis successfully treated with sildenafil.
    Collantes-Rodríguez C; Jiménez-Gallo D; Ossorio-García L; Villegas-Romero I; Linares-Barrios M
    Br J Dermatol; 2020 Jan; 182(1):e1. PubMed ID: 31489611
    [No Abstract]   [Full Text] [Related]  

  • 9. Anti-MDA5 antibody-positive bullous dermatomyositis with thyroid carcinoma.
    Hayami T; Teramura K; Tanaka T; Fujimoto N
    Eur J Dermatol; 2018 Jun; 28(3):418-419. PubMed ID: 30105998
    [No Abstract]   [Full Text] [Related]  

  • 10. Three cases of Anti-MDA5 positive dermatomyositis with interstitial lung disease and pneumomediastium.
    Figueiredo C; Matos AL; Calvao J; Goncalo M
    Dermatol Online J; 2024 Mar; 30(1):. PubMed ID: 38762870
    [No Abstract]   [Full Text] [Related]  

  • 11. Treatment of myopathy and cutaneous ulcers in anti-MDA5-positive dermatomyositis with triple therapy.
    Peringeth G; Abbi B; Mahmood S
    BMJ Case Rep; 2024 Mar; 17(3):. PubMed ID: 38514155
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Successful Treatment of Anti-MDA5 Dermatomyositis Associated Cutaneous Digital Pulp Ulcerations With Hyperbaric Oxygen Therapy.
    Jeter J; Wolf EG; Richards M; Hill E
    J Clin Rheumatol; 2020 Oct; 26(7):e266-e267. PubMed ID: 31833997
    [No Abstract]   [Full Text] [Related]  

  • 13. The clinical spectrum of dermatomyositis and the new autoantibodies - with regard to two clinical cases with distinct associations.
    Calvão da Silva JCM; Santiago L; Brites MM; Gonçalo M
    Australas J Dermatol; 2020 May; 61(2):e241-e243. PubMed ID: 31881093
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Dermatomyositis associated with anti-MDA5 autoantibody].
    Collado MV; Gargiulo MLÁ; Gómez R; Gómez G; Pérez N; Suarez L; Taratuto AL; Aruj P
    Medicina (B Aires); 2018; 78(5):360-363. PubMed ID: 30285929
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antimelanoma Differentiation-associated Gene 5 Dermatomyositis.
    Kurtzman DJB; Weinblatt M; Vleugels RA
    J Rheumatol; 2017 Jun; 44(6):850-851. PubMed ID: 28572474
    [No Abstract]   [Full Text] [Related]  

  • 16. Rapidly progressive interstitial lung fibrosis in a patient with amyopathic dermatomyositis and anti‑MDA5 antibodies.
    Górka J; Szczeklik W; Włudarczyk A; Łoboda P; Chmura Ł; Musiał J
    Pol Arch Med Wewn; 2015; 125(9):685-6. PubMed ID: 26200801
    [No Abstract]   [Full Text] [Related]  

  • 17. Anti-melanoma differentiation-associated gene 5 (MDA5) dermatomyositis: A concise review with an emphasis on distinctive clinical features.
    Kurtzman DJB; Vleugels RA
    J Am Acad Dermatol; 2018 Apr; 78(4):776-785. PubMed ID: 29229575
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MDA5
    Cassius C; Amode R; Delord M; Battistella M; Poirot J; How-Kit A; Lepelletier C; Jachiet M; de Masson A; Frumholtz L; Cordoliani F; Boccara D; Lehmann-Che J; Wong J; Dubanchet S; Alberdi AJ; Merandet M; Bagot M; Bensussan A; Bouaziz JD; Le Buanec H
    J Invest Dermatol; 2020 Jun; 140(6):1276-1279.e7. PubMed ID: 31955963
    [No Abstract]   [Full Text] [Related]  

  • 19. Cutaneous ulceration in juvenile dermatomyositis with anti-melanoma differentiation-associated gene 5.
    Huang B; Huang W; Hao S
    Pediatr Dermatol; 2024; 41(2):342-343. PubMed ID: 37936561
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Dermatomyositis associated with anti-MDA5 antibodies and pneumocystis pneumonia: Two lethal cases].
    Aymonier M; Abed S; Boyé T; Barazzutti H; Fournier B; Morand JJ
    Ann Dermatol Venereol; 2017 Apr; 144(4):279-283. PubMed ID: 27839728
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.